RB Global
RBA NYSE Diversified Support Services Financials FY2016βFY2025
RB Global's revenue rose 7.2% to $4.6 billion in fiscal 2025. Its operating margin was 15.5%, down from 17.8% a year earlier. Free cash flow was $719 million, down 5.9%. It paid out $258 million in dividends and buybacks, 36% of free cash flow. The diluted share count rose 0.9%.
What RB Global does
No business description yet.
- Legal name
- RB Global, Inc
- Fiscal year ends
- December 31, 2025
- Latest annual report
- β
- Accession Β· CIK
- 0001628280-26-011682
0001046102
Revenue and margins
RB Global had $4.6B of revenue in fiscal 2025, up 7.2% on the year before.
Net income and earnings per share
From fiscal 2016 to 2025, diluted EPS grew 10.2% a year. Loss periods are shown in red.
Returns on capital
After-tax operating income as a share of the money invested in the business: debt plus equity, minus cash.
Cash flow
Free cash flow was $719M in fiscal 2025, 15.7% of revenue. Cash from operations minus capital spending.
Dividends, buybacks and share count
RB Global returned $258M to shareholders in fiscal 2025, 36% of free cash flow. The diluted share count rose 0.9%.
Value RB Global yourself
Change the assumptions and see what they imply per share. These are models, not forecasts or price targets β the answer depends entirely on what you put in.
Discounted cash flow
Value per share
β
Adds net cash of β$2.0B and divides by 186.9M diluted shares. Ten years of cash flows plus a terminal value, discounted to today.
Earnings multiple
Value per share
β
Reference multiples: today 36.3x Β· peers 17.9x Β· sector 26.0x.
Balance sheet
Cash, debt and the ratios that show how comfortably RB Global can carry it.
| Fiscal year end | FY21 | FY22 | FY23 | FY24 | FY25 |
|---|---|---|---|---|---|
| Cash and short-term investments | $326M | $494M | $576M | $534M | $532M |
| Debt incl. finance leases | $1.8B | $635M | $3.1B | $2.7B | $2.6B |
| Net debt / EBITDA | 4.4x | 0.3x | 3.1x | 1.8x | 1.7x |
| Debt / equity | 1.7x | 0.5x | 0.6x | 0.5x | 0.5x |
| Interest coverage | 6.5x | 7.8x | 2.2x | 3.3x | 3.7x |
| Current ratio | 1.3x | 1.2x | 1.4x | 1.3x | 1.1x |
| Quick ratio | 1.1x | 1.1x | 1.2x | 1.2x | 1.0x |
| Total assets | $3.6B | $2.9B | $12.0B | $11.8B | $12.1B |
| Total liabilities | $2.5B | $1.6B | $6.5B | $6.1B | $6.1B |
| Shareholders' equity | $1.1B | $1.3B | $5.0B | $5.2B | $5.6B |
| Net debt (β = net cash) | $1.4B | $141M | $2.5B | $2.2B | $2.0B |
Insider trades
Open-market purchases and sales by officers, directors and 10% owners, from Form 4 filings. 'Plan' marks trades under a pre-arranged Rule 10b5-1 plan.
Bought, 12 months
$0.3M
2 insiders
Sold, 12 months
$2.4M
2 insiders
Of sales under plans
100%
$2.4M
| Date | Insider | Trade | Shares | Price | Value | Filing |
|---|---|---|---|---|---|---|
| Sep 9, 2026 | Deborah SteinDirector | Bought | 500 | $80.91 | $0.0M | Form 4 |
| Aug 24, 2026 | Chloe HarfordDirector | Bought | 1,200 | $83.74 | $0.1M | Form 4 |
| Jun 25, 2026 | Christopher CarlsonChief Accounting Officer | Sold plan | 150 | $115.00 | $0.0M | Form 4 |
| May 19, 2026 | Deborah SteinDirector | Bought | 425 | $103.15 | $0.0M | Form 4 |
| May 5, 2026 | Christopher CarlsonChief Accounting Officer | Sold plan | 140 | $110.00 | $0.0M | Form 4 |
| Mar 18, 2026 | Deborah SteinDirector | Bought | 400 | $98.74 | $0.0M | Form 4 |
| Jan 21, 2026 | James Francis KesslerChief Executive Officer | Sold plan | 20,742 | $115.00 | $2.4M | Form 4 |
| Nov 13, 2025 | Deborah SteinDirector | Bought | 1,000 | $101.26 | $0.1M | Form 4 |
Piotroski F-score
Nine pass/fail tests of profitability, funding and efficiency. 8β9 is strong, 0β2 weak.
| Test | FY23 | FY24 | FY25 |
|---|---|---|---|
| Net income is positive | β | β | β |
| Cash from operations is positive | β | β | β |
| Return on assets rose | β | β | β |
| Cash from operations exceeds net income | β | β | β |
| Debt fell relative to assets | β | β | β |
| Current ratio rose | β | β | β |
| Share count didn't rise | β | β | β |
| Gross margin rose | β | β | β |
| Revenue rose relative to assets | β | β | β |
| F-score | 5 / 8 | 4 / 8 | 6 / 8 |
| Accruals ratio | β4.5% | β4.4% | β4.6% |
| Altman Z'' | 1.58 | 1.85 | 1.78 |
Similar companies
Each company's latest fiscal year. Fiscal years end in different months, so periods don't line up exactly.
| Company | Market cap | Growth | Op. margin | FCF margin | ROIC | P/E | F-score | |
|---|---|---|---|---|---|---|---|---|
| RB Global RBA | $15.7B | 7.2% | 15.5% | 15.7% | 7.6% | 36.3x | 6 | |
| Copart CPRT | $27.8B | 0.4% | 35.4% | 27.2% | 19.6% | 18.7x | 4 | Compare β |
| Science Applications Intl SAIC | $6.2B | β2.9% | 7.2% | 8.0% | 12.8% | 17.0x | 7 | Compare β |
| KBR KBR | $5.0B | 1.0% | 10.0% | 6.6% | 15.8% | 11.8x | 7 | Compare β |
| CoreCivic CXW | $3.0B | 12.7% | β | 2.4% | 6.6% | 24.2x | 7 | Compare β |
10 years of figures
US$ millions unless stated. Hover a ratio's name for its definition.
| Fiscal year | FY16 | FY17 | FY18 | FY19 | FY20 | FY21 | FY22 | FY23 | FY24 | FY25 |
|---|---|---|---|---|---|---|---|---|---|---|
| Income statement | ||||||||||
| Revenue | $1.1B | $971M | $1.2B | $1.3B | $1.4B | $1.4B | $1.7B | $3.7B | $4.3B | $4.6B |
| Gross profit | $189M | $532M | β | β | β | β | β | β | β | β |
| Operating income | $136M | $108M | $185M | $223M | $263M | $241M | $454M | $471M | $761M | $713M |
| Interest expense | $5.6M | $38.3M | $44.5M | $41.3M | $35.6M | $37.0M | $57.9M | $214M | $234M | $192M |
| Pretax income | $131M | $77.4M | $153M | $191M | $236M | $205M | $406M | $282M | $550M | $536M |
| Income tax | $37.0M | $2.1M | $31.0M | $41.6M | $65.5M | $53.4M | $86.2M | $76.4M | $137M | $108M |
| Net income | $91.8M | $75.0M | $122M | $149M | $170M | $152M | $320M | $207M | $413M | $428M |
| Diluted EPS | $0.85 | $0.69 | $1.11 | $1.36 | $1.54 | $1.36 | $2.86 | $1.04 | $2.01 | $2.04 |
| Diluted shares | 0.11B | 0.11B | 0.11B | 0.11B | 0.11B | 0.11B | 0.11B | 0.17B | 0.19B | 0.19B |
| Cash flow | ||||||||||
| Cash from operations | $178M | $148M | $144M | $333M | $258M | $318M | $463M | $544M | $932M | $978M |
| Capital expenditure | $18.9M | $10.8M | $16.9M | $13.6M | $14.3M | $9.8M | $32.0M | $228M | $167M | $259M |
| Free cash flow | $159M | $137M | $127M | $319M | $244M | $308M | $431M | $316M | $765M | $719M |
| Depreciation and amortization | $40.9M | $52.7M | $66.6M | $70.5M | $74.9M | $87.9M | $97.2M | $352M | $444M | $483M |
| Stock-based compensation | $19.6M | $19.7M | $23.4M | $12.7M | $16.6M | $31.3M | $41.7M | $55.8M | $62.4M | $66.0M |
| Acquisitions | $0.0M | $0.0M | $0.0M | $0.0M | $0.0M | $0.0M | $0.0M | $2.8B | $8.6M | $193M |
| Share buybacks | $36.7M | $0.0M | $0.0M | $42.0M | $53.2M | $0.0M | $0.0M | $0.0M | $0.0M | $0.0M |
| Dividends paid | $70.5M | $72.8M | $75.7M | $82.5M | $91.7M | $104M | $115M | $298M | $206M | $258M |
| Dividends and buybacks | $107M | $72.8M | $75.7M | $125M | $145M | $104M | $115M | $298M | $206M | $258M |
| Balance sheet | ||||||||||
| Cash and short-term investments | $208M | $268M | $238M | $360M | $279M | $326M | $494M | $576M | $534M | $532M |
| Total debt | $620M | $820M | $731M | $650M | $666M | $1.7B | $611M | $3.1B | $2.7B | $2.5B |
| Finance lease liabilities | $0.0M | $0.0M | $0.0M | $23.9M | $26.3M | $22.9M | $24.7M | $25.9M | $50.6M | $102M |
| Current assets | $378M | $509M | $604M | $680M | $557M | $762M | $963M | $1.8B | $1.7B | $1.8B |
| Current liabilities | $253M | $389M | $440M | $501M | $515M | $588M | $795M | $1.3B | $1.3B | $1.6B |
| Inventory | $28.5M | $38.2M | $113M | $65.0M | $86.3M | $103M | $103M | $167M | $122M | $140M |
| Property and equipment, net | $515M | $527M | $487M | $485M | $492M | $449M | $459M | $1.2B | $1.3B | $1.5B |
| Total assets | $1.6B | $2.0B | $2.1B | $2.2B | $2.4B | $3.6B | $2.9B | $12.0B | $11.8B | $12.1B |
| Total liabilities | $904M | $1.3B | $1.2B | $1.3B | $1.3B | $2.5B | $1.6B | $6.5B | $6.1B | $6.1B |
| Shareholders' equity | $687M | $740M | $831M | $902M | $1.0B | $1.1B | $1.3B | $5.0B | $5.2B | $5.6B |
| Margins | ||||||||||
| Gross margin | 16.7% | 54.7% | β | β | β | β | β | β | β | β |
| Operating margin | 12.0% | 11.1% | 15.8% | 16.9% | 19.1% | 17.0% | 26.2% | 12.8% | 17.8% | 15.5% |
| EBITDA margin | 15.7% | 16.5% | 21.5% | 22.3% | 24.6% | 23.2% | 31.8% | 22.4% | 28.1% | 26.1% |
| Net margin | 8.2% | 7.7% | 10.4% | 11.3% | 12.4% | 10.7% | 18.4% | 5.6% | 9.6% | 9.3% |
| FCF margin | 14.1% | 14.1% | 10.9% | 24.2% | 17.7% | 21.7% | 24.9% | 8.6% | 17.9% | 15.7% |
| Returns | ||||||||||
| Return on capital | 11.4% | 8.7% | 11.2% | 13.7% | 14.4% | 9.1% | 18.1% | 7.7% | 7.6% | 7.6% |
| Return on capital employed | 12.5% | 7.2% | 11.4% | 13.4% | 14.8% | 10.0% | 17.9% | 7.4% | 7.2% | 6.8% |
| Return on equity | 13.2% | 10.5% | 15.5% | 17.2% | 17.8% | 14.6% | 27.1% | 6.6% | 8.1% | 7.9% |
| Return on assets | 6.8% | 4.2% | 6.0% | 7.0% | 7.4% | 5.1% | 9.9% | 2.8% | 3.5% | 3.6% |
| Growth | ||||||||||
| Revenue growth | β | β13.8% | 20.5% | 12.7% | 4.5% | 2.9% | 22.4% | 112.2% | 16.4% | 7.2% |
| Net income growth | β32.6% | β18.3% | 61.9% | 22.7% | 14.1% | β10.7% | 110.5% | β35.4% | 100.1% | 3.7% |
| EPS growth | β33.1% | β18.8% | 60.9% | 22.5% | 13.2% | β11.7% | 110.3% | β63.6% | 93.3% | 1.5% |
| FCF growth | β9.0% | β13.8% | β6.8% | 150.5% | β23.7% | 26.4% | 40.1% | β26.7% | 141.9% | β5.9% |
| Share count change | 0.0% | 0.6% | 1.2% | 0.3% | 0.5% | 1.0% | 0.4% | 50.3% | 10.2% | 0.9% |
| Financial health | ||||||||||
| Net debt / EBITDA | 2.3x | 3.5x | 2.0x | 1.1x | 1.2x | 4.4x | 0.3x | 3.1x | 1.8x | 1.7x |
| Debt / equity | 0.9x | 1.1x | 0.9x | 0.8x | 0.7x | 1.7x | 0.5x | 0.6x | 0.5x | 0.5x |
| Interest coverage | 24.4x | 2.8x | 4.2x | 5.4x | 7.4x | 6.5x | 7.8x | 2.2x | 3.3x | 3.7x |
| Current ratio | 1.5x | 1.3x | 1.4x | 1.4x | 1.1x | 1.3x | 1.2x | 1.4x | 1.3x | 1.1x |
| Quick ratio | 1.4x | 1.2x | 1.1x | 1.2x | 0.9x | 1.1x | 1.1x | 1.2x | 1.2x | 1.0x |
| Capital allocation | ||||||||||
| Capex / revenue | 1.7% | 1.1% | 1.4% | 1.0% | 1.0% | 0.7% | 1.9% | 6.2% | 3.9% | 5.6% |
| Stock comp / revenue | 1.7% | 2.0% | 2.0% | 1.0% | 1.2% | 2.2% | 2.4% | 1.5% | 1.5% | 1.4% |
| Payouts / FCF | 67.6% | 53.2% | 59.4% | 39.0% | 59.5% | 33.7% | 26.7% | 94.3% | 26.9% | 35.9% |
| Quality scores | ||||||||||
| Piotroski F-score | β | 5.0 | 6.0 | 6.0 | 5.0 | 4.0 | 5.0 | 5.0 | 4.0 | 6.0 |
| Altman Z'' | 3.1 | 2.3 | 2.9 | 3.0 | 2.8 | 2.0 | 3.5 | 1.6 | 1.9 | 1.8 |
| Accruals ratio | β6.3% | β4.0% | β1.1% | β8.6% | β3.8% | β5.6% | β4.4% | β4.5% | β4.4% | β4.6% |
Source: SEC EDGAR XBRL filings (CIK 0001046102). Data updated October 18, 2026. Quarterly fourth quarters are the full year minus the first nine months. For information only β not investment advice. Check the original filings before relying on any figure.